Plant molecular farming in the wake of the closure of Medicago Inc
Nat Biotechnol
.
2023 Jul;41(7):893-894.
doi: 10.1038/s41587-023-01812-w.
Authors
Eugenio Benvenuto
1
,
Inge Broer
2
,
Marc-André D'Aoust
3
,
Inga Hitzeroth
4
,
Penny Hundleby
5
,
Rima Menassa
6
,
Kirsi-Marja Oksman-Caldentey
7
,
Hadrien Peyret
5
,
Sancha Salgueiro
8
,
Pooja Saxena
9
,
Jennifer Stander
10
,
Heribert Warzecha
11
,
Julian Ma
12
Affiliations
1
Department for Sustainability, Biotechnology and Agroindustry Division, ENEA, Centro Ricerche Casaccia, Rome, Italy.
2
Faculty of Agricultural and Environmental Sciences, University of Rostock, Rostock, Germany.
3
Medicago R&D, Québec City, Canada.
4
BioPharming Research Unit, Department of Molecular and Cell Biology, University of Cape Town, Cape Town, South Africa.
5
John Innes Centre, Norwich, UK.
6
University of Western Ontario, London, Ontario, Canada.
7
VTT Technical Research Centre of Finland, Espoo, Finland.
8
Chart Biotechnology, Gilleleje, Denmark.
9
BlueRock Therapeutics, Toronto, Ontario, Canada.
10
Cape Bio Pharms, Cape Town, South Africa.
11
Technical University of Darmstadt, Darmstadt, Germany.
12
St. George's, University of London, London, UK. jma@sgul.ac.uk.
PMID:
37217754
DOI:
10.1038/s41587-023-01812-w
No abstract available
Publication types
Letter
MeSH terms
Gene Expression Regulation, Plant
Medicago truncatula* / metabolism
Medicago* / metabolism
Molecular Farming
Plant Proteins / genetics
Plant Roots
Substances
Plant Proteins